nalmefene has been researched along with Cocaine Abuse in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grosshans, M; Kiefer, F; Mutschler, J | 1 |
Borg, L; Gunduz, M; Ho, A; Kreek, MJ; Schluger, J | 1 |
1 trial(s) available for nalmefene and Cocaine Abuse
Article | Year |
---|---|
Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Dynorphins; Female; Humans; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments; Prolactin; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Time Factors | 1999 |
1 other study(ies) available for nalmefene and Cocaine Abuse
Article | Year |
---|---|
Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience.
Topics: Adult; Behavior, Addictive; Cocaine-Related Disorders; Craving; Drug Partial Agonism; Female; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Recurrence; Time Factors; Treatment Outcome | 2015 |